Perceptive Advisors LLC Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Perceptive Advisors LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 14, 2019	SELL	$29.75 - $42.9 $29.5 Million - $42.5 Million	-990,943 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$32.79 - $43.0 $57.5 Million - $75.4 Million	-1,752,704 Reduced 63.88%	990,943 $37.2 Million
Q2 2018 Aug 14, 2018	SELL	$23.62 - $42.29 $4.34 Million - $7.77 Million	-183,802 Reduced 6.28%	2,743,647 $108 Million
Q1 2018 May 15, 2018	BUY	$22.49 - $34.56 $60 Million - $92.1 Million	2,666,315 Added 1021.05%	2,927,449 $71.2 Million
Q4 2017 Feb 14, 2018	SELL	$20.44 - $35.56 $919,800 - $1.6 Million	-45,000 Reduced 14.7%	261,134 $7.05 Million
Q3 2017 Nov 14, 2017	BUY	$23.54 - $38.21 $7.21 Million - $11.7 Million	306,134	306,134 $11.4 Million

785K

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $3.65B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

Get notified when there are updates to the investment portfolio of Perceptive Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Perceptive Advisors LLC with notifications on news.